The principal arachidonate product of rat preglomerular microvessels (PGMV), 20-HETE, is an essential component in key renal vascular mechanisms that govern renal blood flow (autoregulation) and glomerular filtration rate (tubuloglomerular feedback). Therefore, identifying and characterizing those factors that determine synthesis and activity of 20-HETE are key to understanding the control of renal function. The proposed studies are based primarily on two experimental preparations: rat isolated PGMV and pressurized renal arcuate-interlobular arteries that provide complementary data. A third preparation, interlobar and arcuate arteries will provide additional information on eicosanoid metabolism as affected by changes in oxygenase enzyme activity under various experimental conditions. The biochemical effects of vasoactive peptides on PGMV will be correlated with changes in reactivity of pressurized arteries to the peptide challenge. They postulate four major factors that modify either the synthesis or effects of 20-HETE: 1) NO decreases 20-HETE synthesis by inhibiting w hydroxylases. 2) COX metabolizes 20-HETE to prostaglandin analogs (20-OH-PG) that differ in their biological activity from 20-HETE. Further, analogs produced by COX-1 differ from those produced by COX-2. 3) EETs (11,12-EET?) that antagonize the vasoconstrictor response to 20-HETE. 4) AT2 mediates Ang II-induced increases in 20-HETE levels in PGMV. Perturbation of the above factors by high and low salt diets will be related to effects on synthesis and vascular actions of 20-HETE.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
5R01HL025394-26
Application #
6737500
Study Section
Cardiovascular and Renal Study Section (CVB)
Program Officer
Lin, Michael
Project Start
1979-06-01
Project End
2005-05-31
Budget Start
2004-06-01
Budget End
2005-05-31
Support Year
26
Fiscal Year
2004
Total Cost
$399,371
Indirect Cost
Name
New York Medical College
Department
Pharmacology
Type
Schools of Medicine
DUNS #
041907486
City
Valhalla
State
NY
Country
United States
Zip Code
10595
Li, Jing; Stier, Charles T; Chander, Praveen N et al. (2014) Pharmacological manipulation of arachidonic acid-epoxygenase results in divergent effects on renal damage. Front Pharmacol 5:187
Carroll, Mairead A (2012) Role of the adenosine(2A) receptor-epoxyeicosatrienoic acid pathway in the development of salt-sensitive hypertension. Prostaglandins Other Lipid Mediat 98:39-47
Jiang, Houli; Harrison, Fiona E; Jain, Kavita et al. (2012) Vitamin C activation of the biosynthesis of epoxyeicosatrienoic acids. Adv Biosci Biotechnol 3:204-218
Jiang, Houli; Quilley, John; Doumad, Anabel B et al. (2011) Increases in plasma trans-EETs and blood pressure reduction in spontaneously hypertensive rats. Am J Physiol Heart Circ Physiol 300:H1990-6
Quilley, J; Santos, M; Pedraza, P (2011) Renal protective effect of chronic inhibition of COX-2 with SC-58236 in streptozotocin-diabetic rats. Am J Physiol Heart Circ Physiol 300:H2316-22
Quilley, John (2010) Oxidative stress and inflammation in the endothelial dysfunction of obesity: a role for nuclear factor kappa B? J Hypertens 28:2010-1
Jiang, Houli; Anderson, Gail D; McGiff, John C (2010) Red blood cells (RBCs), epoxyeicosatrienoic acids (EETs) and adenosine triphosphate (ATP). Pharmacol Rep 62:468-74
Liclican, Elvira L; Doumad, Anabel B; Wang, Jianjin et al. (2009) Inhibition of the adenosine2A receptor-epoxyeicosatrienoic acid pathway renders Dahl salt-resistant rats hypertensive. Hypertension 54:1284-90
Minuz, Pietro; Jiang, Houli; Fava, Cristiano et al. (2008) Altered release of cytochrome p450 metabolites of arachidonic acid in renovascular disease. Hypertension 51:1379-85
Jiang, Houli; Zhu, Angela G; Mamczur, Magdalena et al. (2008) Hydrolysis of cis- and trans-epoxyeicosatrienoic acids by rat red blood cells. J Pharmacol Exp Ther 326:330-7

Showing the most recent 10 out of 105 publications